Tag: OCLS

Cannabis Stocks, OXBT, SEED & Extended Watchlist

Continuing Cannabis Coverage

We mentioned yesterday that despite some slight pullbacks in a few of our marijuana-related stocks on Friday, that we had better be on the lookout for rebound action. There were definitely some opportunities for that provided by some of our favorite ‘pot stocks’. The majority of the sector did indeed experience further gains, and we certainly saw tons of volume on all accounts. Here are a few of the more stand-out performances from this sector that we have been tracking heavily for an extended period:

GreenGrow Technologies, Inc. GRNH

GRNH continued its multi-day run on Monday. This was one of the ones that did not pull back on Friday. GRNH has been on a strong uptrend since we caught it toward the end of last week as it was trading at .045, and as of yesterday’s high of .185, the stock had given us the chance to make up to 311% in profits in just three sessions.

GrowLife, Inc. PHOT

We’ve seen a low of .157 out of PHOT so far in 2014, and yesterday the stock continued to push upward, touching .239. That marks a solid 52% move since last Thursday.

Tranzbyte Corp. ERBB

ERBB saw a low of .0026 before surging as high as .0035, marking an intraday move of 35% on almost 10X its average volume.

Terra Tech Corp. TRTC

TRTC made a nice move on Monday as well, trading from its daily low at .157 up to .185 for a 16% intraday gain. This came on roughly three times the average volume.

Creative Edge Nutrition, Inc. FITX

FITX managed a gain of 15% on nearly 4X its 3mo. average volume, as it traded in a daily range from .0054-.0062

Oxygen Biotherapeutics, Inc. OXBT

We liked the session put up by OXBT following its inclusion in yesterday’s extended watchlist. The stock made a solid 15% move from 5.5788 up to 6.44 on heavy volume. We’ll continue to keep an eye on this play moving forward. The company has news out today, announcing a couple of upcoming conference appearances.

MORRISVILLE, N.C., Jan 07, 2014 (BUSINESS WIRE) — –Biotech Showcase(TM) 2014 on January 15thOxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that it is scheduled to present at two upcoming healthcare investor conferences in San Francisco.

Oxygen Biotherapeutics’ Chief Executive Officer, John Kelley will deliver a Company presentation at the OneMedForum on Monday, January 13th at 11:30am and the Biotech Showcase(TM) 2014 Conference on Wednesday, January 15th at 11:30am. Mr. Kelley will provide an update on the business operations, including the acquisition of certain assets of Phyxius Pharma Inc. and the development and near-term commercialization of levosimendan to prevent and treat cardiac surgery patients at risk for developing low cardiac output syndrome (LCOS).

AmeraMex International, Inc. AMMX

AMMX first appeared in our extended watchlist last Monday, and once again yesterday. During yesterday’s session we observed as the stock traded in a range from .0064-.0085, a 33% move. From last week’s low of .0047, that’s a gain of up to 81%

AMMX closed at the .0085 high of day on greater-than-average volume. Couple that fact with some of the indicators on the current AMMX chart, and this shows itself as a momentum play of great interest for the remainder of the week.


Origin Agritech, Inc. SEED

Another interesting pick from yesterday’s extended watchlist was SEED. The stock traded in a daily range from 2.15 up to 2.67 (+24%), and finished on a strong note 2.56.  We can see that SEED is gapping up this morning, with premarket trades going off as high as 2.95. We’ll be eager to see how much more this play can continue to push the envelope.

Extended Watchlist:
PLUG, NBIX, STXS, VRS, RIBT, OCLS, HEB

PHOT, CYTR, RNN & Extended Watchlist

Growlife, Inc. PHOT

We’re looking toward PHOT once again today, this old favorite of ours has provided us with opportinuties on countless occasions, and yesterday the company had some important news hit the wire. The company has enlisted the services of former Microsoft and Yahoo! exec, Marco Hegyi, to serve as Growlife’s President. The company is also set to begin a $40M capital infusion from a Nevada private investment group called CANX USA.

For these reasons, as well as the ripening conditions on the chart, we felt we needed to bring PHOT once again to the foreground of our discussions. We also prepared a video chart presentation for your convenience.

WOODLAND HILLS, Calif., Dec. 11, 2013 /PRNewswire via COMTEX/ — GrowLife, Inc. (OTCBB: PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services addressing the needs of legal cannabis growing and retail operations, including hydroponic growing equipment and retail support software, is pleased to announce that effective immediately, Marco Hegyi will assume the position of President and join the Board of Directors.

CytRx Corp. CYTR

CYTR put forth an exciting day of trading yesterday, with the stock undergoing several bounces. The stock opened at 3.90, and hit a subsequent high of 4.39 (+13%). We then saw a pullback to 3.45, and a bounce to 3.74 (+8%). This was followed by bounce from 3.55 to 4.02 (+13%), it pulled back again, and made another swing, this time from 3.60 to 4.05. (+13%)

Flippers certainly had the chance to have a field day with this one, with possible cumulative gains on the order of 47% presenting themselves.

Rexhan Pharmaceuticals, Inc. RNN

RNN came off of yesterday’s extended watchlist to provide our readers with a chance for a nice flip, trading from a low of .4026 to a high of .5179. That move represents an intraday gain of up to 29% on roughly 10X the posted 3mo. average volume.

Extended Watchlist:
OCLS, SNTA, BAXS, ASTC, AVNR
IMUC & SYN – Big gap downs, looking for possible bounces

PLUG, BLDP, MACK & Extended Watchlist

Plug Power, Inc. PLUG
–
We had a feeling that PLUG was going to continue its run yesterday, as stated in our daily report, and once again our instincts served us well. The momentum built up in this stock on Wednesday as it made a 23% move to close out the session on more than 6x the 3mo. average volume was impossible to ignore.

After opening at the key resistance point we outlined (1.45) PLUG briefly dipped to 1.43 and then barreled upward as it touched a high of 1.96, an intraday gain of 37% on roughly 14x the average volume. The momentum continued to build in PLUG and we continued to follow along closely. Remember, our coverage of this play goes back a long way, since the stock was trading in the .11-range.

This morning, the stock is gapping up above 2.00. The current pre-market high of 2.19 represents a gain of 1804% from the low following our first ever PLUG alert back on Feb 28th. The gain from our recent re-alert at a low of 1.04, at this morning’s high, stands at 111%

PLUG has certainly surpassed any expectations we had for it, and as you can see on the chart below, it appears currently overbought, which means the time to take profits off of the table is fast approaching. For newcomers, we believe the best action would be to patiently await a dip, and subsequent rebound, as has occurred several times this year.

Ballard Power Systems, Inc. BLDP

BLDP appeared on our extended watchlist on Wednesday, at which time the stock was trading at a low of 1.34. This morning, we are witnessing a gap-up on a PR that hit the wire post-market yesterday, with trades currently going off in the 1.80-range. We’ll want to keep an eye on the activity here as we close out the week, so we’re reserving a spot on our tickers for BLDP.

VANCOUVER, Dec. 5, 2013 /PRNewswire via COMTEX/ — Ballard Power Systems (NASDAQ: BLDP)(TSX: BLD) has announced the signing of a non-binding Memorandum of Understanding (MOU) with Van Hool NV, Europe’s fourth largest bus manufacturer, in support of the manufacture and further deployment of zero emission fuel cell buses.>>>FULL STORY

Merrimack Pharmaceuticals, Inc. MACK

MACK is another play we’ve been tracking recently, mentioning it for the first time on November 8th, when it was trading as low as 2.40. Like the previous play, MACK is gapping up this morning to the tune of more than 100% with shares changing hands for more than 4.80.

CAMBRIDGE, Mass., Dec. 6, 2013 (GLOBE NEWSWIRE) — Merrimack Pharmaceuticals, Inc. (MACK) today announced that Phase 1 data evaluating safety of the novel agent MM-302 in patients with advanced HER2-positive breast cancer will be presented at the 2013 San Antonio Breast Cancer Symposium (SABCS), December 10-14, 2013 in San Antonio, Texas.  >>> FULL STORY

Extended Watchlist:
GERN, BOSC, CPST, FCEL, PSUN, ENZN, ETAK, OCLS